Posted inPharmaceuticalBristol Myers Squibb Q3 2026 Results: What the Pipeline Data on CELMoDs and Admilparant ShowThe Bristol Myers Squibb Q3 2026 results include CELMoD, admilparant and RYZ101 updates. What each result shows and what is pending.October 30, 2026 Posted inBio TechnologyLaurus Labs Galenvs Acquisition: The Oligonucleotide and Nanoparticle Technology Behind the DealThe Laurus Labs Galenvs acquisition buys oligonucleotide and nanoparticle skills. What the technology involves and what is not shown.October 30, 2026 Posted inHealthcare ServicesFortis Healthcare Acquisition of Suguna Hospital: What Consolidation Means for Care Quality in BengaluruThe Fortis Healthcare acquisition adds 110 beds in north-west Bengaluru. What evidence says about hospital deals and quality.October 30, 2026
Posted inBio TechnologyLaurus Labs Galenvs Acquisition: The Oligonucleotide and Nanoparticle Technology Behind the DealThe Laurus Labs Galenvs acquisition buys oligonucleotide and nanoparticle skills. What the technology involves and what is not shown.October 30, 2026 Posted inHealthcare ServicesFortis Healthcare Acquisition of Suguna Hospital: What Consolidation Means for Care Quality in BengaluruThe Fortis Healthcare acquisition adds 110 beds in north-west Bengaluru. What evidence says about hospital deals and quality.October 30, 2026
Posted inHealthcare ServicesFortis Healthcare Acquisition of Suguna Hospital: What Consolidation Means for Care Quality in BengaluruThe Fortis Healthcare acquisition adds 110 beds in north-west Bengaluru. What evidence says about hospital deals and quality.October 30, 2026
Posted inLife Science LCA-0061 Food Allergy Drug: Early IgE Data, Real LimitsLCA-0061 food allergy drug explained: how Lycia’s IgE degrader works, what the early 96% IgE data show, and what they do not.October 20, 2026
Posted inLife Science Bipolar Mania Drug Research: How RAP-219 Targets AMPA ReceptorsBipolar mania drug research: how RAP-219 targets AMPA receptors, what the Phase 2 trial found, and what one trial cannot yet show.October 20, 2026
Posted inMedical Device Anaesthesia Workstation Manufacturer BPL Bets Big on MedecAnaesthesia workstation manufacturer BPL takes a majority stake in Medec. What the products, patents and pipeline are, and what is undisclosed.October 19, 2026
Posted inMedical Device Indigenous Medical Devices India Get an ICMR Boost: Seven CentresIndigenous medical devices India: ICMR picks seven research centres with up to Rs 15 crore each. What it means and what is still unknown.October 19, 2026
Posted inHealthcare Services Hospital Food Safety India: What the Fortis Mulund Case ShowsHospital food safety India explained: how licensing works and what the Fortis Mulund kitchen suspension does and does not mean.October 19, 2026
Posted inHealthcare Services Kenya Confirms Eighth Ebola Case: Hospital Attendant Tests PositiveKenya Ebola cases reach eight after a hospital patient attendant tests positive. A case-by-case timeline and contact-tracing figures.October 19, 2026
Posted inMedical Device Sahajanand Medical Technologies IPO Closes Today: Price Band, Issue Size and Business ExplainedSahajanand Medical Technologies IPO closes today: price band, offer-for-sale structure, allotment dates and the stent maker’s business.October 19, 2026
Posted inPharmaceutical India Caps Trade Margins on 137 Cancer Drugs: What the NPPA Order DoesCancer drug price cap India: how the NPPA 30% trade-margin order on 137 medicines works, its legal basis, and how it compares with 2019.October 19, 2026
Posted inMedical Device FDA Flags Four Edwards Commander M Delivery System Lots After Death and Serious Injury ReportEdwards Lifesciences recall alert: FDA names four Commander M delivery system lots used with SAPIEN M3 after reported balloon ruptures. Lot numbers inside.October 16, 2026
Posted inPharmaceutical South Africa Plans New Rules for Compounded Weight-Loss DrugsSouth Africa is drafting standards for compounded weight-loss drugs. A timeline of enforcement and what is legal today versus proposed.October 16, 2026